"Tumor-Free Survival" Outweighs the Side Effects of Combined Anti-EGF Therapy and Chemotherapy in Patients With NSCLC. Makarem M, Janne PA. J Thorac Oncol 2024;19:1151-1154.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Makarem M, Janne PA. "Tumor-Free Survival" Outweighs the Side Effects of Combined Anti-EGF Therapy and Chemotherapy in Patients With NSCLC. J Thorac Oncol 2024;19:1151-1154.
PMID: 39112002